Education
About Us
Working with TipRanks
Follow Us
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI
Karyopharm Therapeutics (KPTI) Ownership Overview
9.42% Insiders
34.90% Mutual Funds
<0.01% Other Institutional Investors
4.21% ETFs
51.47% Public Companies and Individual Investors
The ownership structure of Karyopharm Therapeutics (KPTI) stock is a mix of institutional, retail, and individual investors. Approximately 39.12% of the company’s stock is owned by Institutional Investors, 9.42% is owned by Insiders, and 51.47% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,125,000 | Institution | 13.02% | 4,770,000 | |
| 533,333 | Institution | 6.17% | 2,261,332 | |
| 402,887 | Institution | 4.66% | 1,708,241 | |
| 391,054 | Insider | 4.53% | 1,658,069 | |
| 345,607 | Institution | 4.00% | 1,465,374 | |
| 337,632 | Institution | 3.91% | 1,431,560 | |
| 169,383 | Institution | 1.96% | 718,184 | |
| 160,000 | Insider | 1.85% | 678,400 | |
| 134,112 | Institution | 1.55% | 568,635 | |
| 133,876 | Institution | 1.55% | 567,634 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,125,000 | Institution | 13.02% | 4,770,000 | |
| 533,333 | Institution | 6.17% | 2,261,332 | |
| 402,887 | Institution | 4.66% | 1,708,241 | |
| 337,632 | Institution | 3.91% | 1,431,560 | |
| 169,383 | Institution | 1.96% | 718,184 | |
| 133,876 | Institution | 1.55% | 567,634 | |
| 85,896 | Institution | 0.99% | 364,199 | |
| 74,926 | Institution | 0.87% | 317,686 | |
| 46,618 | Institution | 0.54% | 197,660 | |
| 43,876 | Institution | 0.51% | 186,034 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 228,100 | Institution | 2.64% | 958,020 | |
| 117,507 | Institution | 1.36% | 493,529 | |
| 42,012 | Institution | 0.49% | 44,533 | |
| 17,428 | Institution | 0.20% | 73,895 | |
| 792 | Institution | <0.01% | 3,778 |
FAQ
Who Owns Karyopharm Therapeutics (KPTI)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 9.42% is held by insiders, and 51.47% is held by retail investors.
What percentage of Karyopharm Therapeutics (KPTI) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Karyopharm Therapeutics (KPTI) stock is held by institutional investors.
What percentage of Karyopharm Therapeutics (KPTI) stock is held by retail investors?
According to the latest TipRanks data, approximately 51.47% of Karyopharm Therapeutics (KPTI) stock is held by retail investors.
Who owns the most shares of Karyopharm Therapeutics (KPTI)?
MUTUAL FUND SERIES TRUST owns the most shares of Karyopharm Therapeutics (KPTI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.